Investor Type | Firm |
Industries | IT (& TMT) • BioTech • Hardware (& Manufacturing) • Material Science • Medical Devices (& Hospital Services) • Life Science • Pharmaceutical (& Medicine) |
Stages | Early |
VI Partners is a venture capital firm based in Altendorf, Switzerland, dedicated to funding and nurturing innovative ventures in a diverse array of industries. With an investment strategy that encompasses early stage and growth financing, they focus on empowering organizations within the biotechnology, health care, and software sectors, as well as IT, TMT, hardware, manufacturing, material science, medical devices, hospital services, life sciences, and pharmaceuticals. VI Partners is known for their commitment to healthcare and technology (Tech) companies, as evidenced by their active engagement in groundbreaking research and support of advancements in AI, gene therapy, and digital health. Their portfolio includes companies that are not only developing new therapies for phagocyte disorders and tackling non-druggable proteins with AI, but also revolutionizing patient care through innovations like AI-based digital cognitive assessments and digital coaching for personnel development. Furthermore, the firm takes pride in funding start-ups aiming to redefine leasing through cutting-edge technology and those contributing to the structural heart space. The firm's significant involvement in the financing rounds of companies such as Almer Technologies, FLOWIT AG, and LeaseTeq highlights its strategy to lead investments and drive innovation further. VI Partners also values thought leadership in the tech field, engaging in discourse on career navigation for tech professionals and exploring the impact of AI on venture capital and the broader economy. Through their CEO Day, they facilitate knowledge sharing and networking among entrepreneurs and key ecosystem players. As a principal venture capital firm in Switzerland, VI Partners has a legacy that dates back to its founding team's advisory role for Venture Incubator, with support from influential Swiss companies and institutions like ETHZ. The current investment approach is geared towards the European tech and healthcare markets, aiming to back start-ups that could become future leaders, particularly in the B2B SaaS sector. By championing entrepreneurs, VI Partners aligns with the credo that these innovators possess the power to improve the world.